Home›Stock Screener›Hemadri Cements›Financial Statements

Hemadri Cements Financial Statements

11 Years of Data
2025 - 2015

Hemadri Cements financial statements. In FYNone, Hemadri Cements (HEMACEM) reported revenue ₹1 Cr, net profit ₹-19 Cr and EPS ₹-27.80, with a net profit margin of -262.5%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read HEMACEM dividend yield for the complete payout history and dividend yield track record.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -262.50% 2025 data
EBITDA Margin -237.50% 2025 data
Operating Margin -243.00% 2025 data
Return on Assets -87.50% 2025 data

Balance Sheet Ratios

Current Ratio 0.52 2025 data
Equity Ratio -16.67% 2025 data
Asset Turnover 0.33 2025 data

HEMACEM Revenue, Net Profit & EBITDA — Year-on-Year Growth

HEMACEM YoY (March 2025 vs Period) — revenue -87.5%, net profit +9.5%, EBITDA +47.4%, expenses -59.3%. For live price, earnings ratios and company overview, see HEMACEM share price screener.

Revenue Growth
-87.5%
Year-over-Year
Net Profit Growth
+9.5%
Year-over-Year
EBITDA Growth
+47.4%
Year-over-Year
Expense Growth
-59.3%
Year-over-Year
Assets Growth
-50.0%
Year-over-Year
Equity Growth
-117.4%
Year-over-Year
Liabilities Growth
-50.0%
Year-over-Year
Operating Cash Flow Growth
+118.2%
Year-over-Year
Financing Cash Flow Growth
-133.3%
Year-over-Year

HEMACEM Income Statement — Revenue, EBITDA & Net Profit

Hemadri Cements revenue ₹1 Cr, EBITDA ₹-10 Cr, net profit ₹-19 Cr, EPS ₹-27.80 (None) — net profit margin -262.5%. Analyse HEMACEM FII DII holdings to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 1 8 57 71 84 96 71 80 83 86 93 85
Expenses 11 27 66 88 81 90 68 77 81 78 81 74
EBITDA -10 -19 -10 -18 3 6 2 3 2 9 12 11
Operating Profit Margin % 0.00% -243.00% -19.00% -29.00% 1.00% 6.00% 3.00% -3.00% 2.00% 9.00% 12.00% 12.00%
Depreciation 2 2 2 2 2 2 1 1 1 1 1 1
Interest 2 1 1 1 0 0 1 1 0 0 0 0
Profit Before Tax -13 -21 -13 -21 0 4 0 1 1 8 11 10
Tax 0 0 -2 -5 0 3 0 0 0 7 4 3
Net Profit -19 -21 -11 -15 0 1 0 1 1 1 7 7
Earnings Per Share (₹) -27.80 -40.57 -16.39 -22.93 0.64 1.82 0.20 1.54 0.73 1.63 9.75 10.21

HEMACEM Balance Sheet — Assets, Liabilities & Shareholders' Equity

HEMACEM total assets ₹24 Cr, total equity ₹-4 Cr, total liabilities ₹24 Cr (2025).

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 24 48 56 72 67 64 66 63 62 62 57
Current Assets 11 26 27 40 34 25 26 30 30 31 27
Fixed Assets 11 12 14 15 17 19 10 11 11 8 8
Capital Work in Progress 1 1 1 1 0 0 9 0 0 1 0
Investments 4 1 1 1 1 1 1 1 1 0 0
Other Assets 0 35 42 56 49 45 47 52 50 53 48
LIABILITIES
Total Liabilities 24 48 56 72 67 64 66 63 62 62 57
Current Liabilities 21 2 2 2 2 0 0 1 1 1 1
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity -4 23 34 50 49 48 48 47 46 45 39
Share Capital 7 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus -11 16 28 43 42 41 41 40 40 39 32

HEMACEM Cash Flow Statement — Operating, Investing & Financing

Hemadri Cements operating cash flow ₹2 Cr, investing ₹0 Cr, financing ₹-2 Cr, net cash flow ₹0 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 2 -11 -5 12 2 -4 -1 6 1 2
Investing Activities 0 0 -1 0 0 -9 0 -3 -1 0
Financing Activities -2 6 5 -6 -2 6 0 0 0 0
Net Cash Flow 0 -6 -1 6 0 -7 -1 3 0 2